第一单位：
Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
作者：
Rebecca,Silbermann [1]
;
Jacob,Laubach [2]
;
Jonathan L,Kaufman [3]
;
Douglas W,Sborov [4]
;
Brandi,Reeves [5]
;
Cesar,Rodriguez [6]
;
Ajai,Chari [6]
;
Luciano J,Costa [7]
;
Larry D,Anderson [8]
;
Nitya,Nathwani [9]
;
Nina,Shah [10]
;
Naresh,Bumma [11]
;
Sarah A,Holstein [12]
;
Caitlin,Costello [13]
;
Andrzej,Jakubowiak [14]
;
Robert Z,Orlowski [15]
;
Kenneth H,Shain [16]
;
Andrew J,Cowan [17]
;
Katharine S,Gries [18]
;
Huiling,Pei [19]
;
Annelore,Cortoos [20]
;
Sharmila,Patel [20]
;
Thomas S,Lin [20]
;
Peter M,Voorhees [21]
;
Saad Z,Usmani [22]
;
Paul G,Richardson [2]
作者单位：
Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
[1]
Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA.
[2]
Department of Mematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
[3]
Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
[4]
Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
[5]
Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA.
[6]
Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
[7]
Division of Hematology/Oncology, Simmons Comprehensive Cancer Center, UT Texas Southwestern Medical Center, Dallas, Texas, USA.
[8]
Division of Myeloma, Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
[9]
Department of Medicine, University of California San Francisco, San Francisco, California, USA.
[10]
Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
[11]
Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
[12]
Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, California, USA.
[13]
Medicine- Hematology and Oncology, University of Chicago, Chicago, Illinois, USA.
[14]
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
[15]
Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
[16]
Department of Medicine, University of Washington, Seattle, Washington, USA.
[17]
Janssen Research & Development, Raritan, New Jersey, USA.
[18]
Janssen Research & Development, LLC, Titusville, New Jersey, USA.
[19]
Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA.
[20]
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest University School of Medicine, Charlotte, North Carolina, USA.
[21]
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[22]
DOI
10.1002/ajh.27326
PMID
38622840
发布时间
2025-07-19
换一批
